Psoriasis | Pharmacor | G7 | 2014
Last Updated 28 October 2014
Psoriasis is a skin disorder that, depending on its severity and location on the body, can have a major impact on patients’ quality of life. It is generally characterized as mild or moderate to severe and can be accompanied by the debilitating joint disease psoriatic arthritis (PsA). We expect the psoriasis therapy market to experience substantial growth over the 2013-2023 forecast period as a result of the launches of several new therapies and increasing drug-treatment rates.
